Back to search
FDAFDA · Food and drugs·Recall number D-1128-2017

Propafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx only, Manufactured By: Watson Pharmaceuticals 311 Bonnie Circle Corona, CA 92880, NDC 63739-509-10

Published September 13, 2017 · Recall initiated: August 28, 2017

Summary

FDA records drug Class III recall D-1128-2017, published September 13, 2017 and initiated August 28, 2017. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 3966 unit-dose boxes; Lot: Lot#: 0112313 Exp. 12/2017; 0113376 Exp. 06/2018; 0113645 Exp. 02/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed moisture limits: Out of specification for moisture content.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
PA, OH, IL, CO, LA
Lot
Lot#: 0112313 Exp. 12/2017; 0113376 Exp. 06/2018; 0113645 Exp. 02/2019.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx only, Manufactured By: Watson Pharmaceuticals 311 Bonnie Circle Corona, CA 92880, NDC 63739-509-10 recalled?

Yes. FDA published recall D-1128-2017 on September 13, 2017. Reported hazard: Failed moisture limits: Out of specification for moisture content.

What should I do if I have this product?

Voluntary: Firm initiated · Letter